Osamu Abe
Papers
2
Total Citations
10
H-Index
2
About
Osamu Abe is a leading figure in the surgical and radiotherapeutic management of localized prostate cancer, with a focused research program dedicated to comparing the long-term efficacy of modern treatment modalities. His major contributions center on head-to-head evaluations of robot-assisted radical prostatectomy (RARP) against volumetric modulated arc therapy (VMAT), a cutting-edge form of intensity-modulated radiotherapy. In a landmark 2019 study, Abe provided one of the first direct comparisons of these front-line therapies, analyzing oncological and functional outcomes. He extended this work with a 2024 propensity score-matched analysis, which uniquely examined six-year mortality outcomes—a critical gap in the literature. While his most-cited papers have accumulated approximately 10 citations, their significance lies in addressing a fundamental clinical question: how do these advanced surgical and radiotherapeutic techniques truly compare in real-world practice? Abe’s work is particularly notable for its rigorous methodology and long-term follow-up, offering urologists and radiation oncologists evidence-based guidance for treatment selection. His research continues to shape decision-making in localized prostate cancer care.
Research Focus
Key Achievements
Top Papers
- 1
- 2